Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children

Neurology

Volumn 76, Issue 15, 2011, Pages 1338-1343

  Arya, R ^a   Gulati, S ^a,e   Kabra, M ^b   Sahu, J K ^c   Kalra, V ^d  

^a Department of Pediatrics   (India)

^b Department of Pediatrics ^*  (India)

^c GOVERNMENT OF INDIA   (India)

^d INDRAPRASTHA APOLLO HOSPITAL   (India)

^e ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; PHENYTOIN; PLACEBO;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED DISEASE; EPILEPSY; GINGIVA OVERGROWTH; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; OUTCOME ASSESSMENT; PHENYTOIN INDUCED GINGIVA OVERGROWTH; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SCHOOL CHILD; TERTIARY HEALTH CARE; TREATMENT DURATION; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

EID: 79954576016     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182152844     Document Type: Article

References (19)

1. Merritt HH, Putnam TJ. Sodium diphenylhydantoinate in the treatment of convulsive disorders. JAMA 1938;111: 1068-1073.
2. Kimball OP. The treatment of epilepsy with sodium diphenylhydantoinate. JAMA 1939;112:1244.
3. Angelopoulos AP, Goaz PW. Incidence of diphenylhydantoin gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1972;34:898-906.
4. Seymour RA. Drug-induced gingival overgrowth. Adverse Drug React Toxicol Rev 1993;12:215-232.
5. Prasad VN, Chawla HS, Goyal A, Gauba K, Singhi P. Incidence of phenytoin induced gingival overgrowth in epileptic children: a six month evaluation. J Indian Soc Pedod Prev Dent 2002;20:73-80.
6. Inoue F, Harrison JV. Folic acid and phenytoin hyperplasia. Lancet 1981;2:86. (Pubitemid 11069881)
7. Brown RS, Di Stanislao PT, Beaver WT, Bottomley WK. The administration of folic acid to institutionalized epileptic adults with phenytoin-induced gingival hyperplasia: a double-blind, randomized, placebo-controlled, parallel study. Oral Surg Oral Med Oral Pathol 1991;71:565-568.
8. Drew HJ, Vogel RI, Molofsky W, Baker H, Frank O. Effect of folate on phenytoin hyperplasia. J Clin Periodontol 1987;14:350-356.
9. Burt B, Eklund SA, Eklund S. Dentistry, Dental Practice, and the Community, 6th ed. Philadelphia: Elsevier Health Sciences; 2005.
10. Bos A HJ, Prahl-Andersen B. Dutch primary schoolchildren's attitudes toward their dental appearance. Pediatr Dent 2008;30:439-442.
11. Steinberg SC, Steinberg AD. Phenytoin-induced gingival overgrowth control in severely retarded children. J Periodontol 1982;53:429-433. (Pubitemid 12055107)
12. Westphal P. Dental care of epileptics. Epilepsia 1972;13: 233-237.
13. Prasad VN, Chawla HS, Goyal A, Gauba K, Singhi P. Folic acid and phenytoin induced gingival overgrowth-is there a preventive effect. J Indian Soc Pedod Prev Dent 2004;22:82-91.
14. Conard GJ, Jeffay H, Boshes L, Steinberg AD. Levels of 5,5-diphenylhydantoin and its major metabolite in human serum, saliva, and hyperplastic gingiva. J Dent Res 1974; 53:1323-1329.
15. Little TM, Girgis SS, Masotti RE. Diphenylhydantoininduced gingival hyperplasia: its response to changes in drug dosage. Dev Med Child Neurol 1975;17:421-424.
16. Addy V, McElnay JC, Eyre DG, Campbell N, D'Arcy PF. Risk factors in phenytoin-induced gingival hyperplasia. J Periodontol 1983;54:373-377. (Pubitemid 13010360)
17. Kapur RN, Girgis S, Little TM, Masotti RE. Diphenylhydantoin-induced gingival hyperplasia: its relationship to dose and serum level. Dev Med Child Neurol 1973;15:483-487.
18. Ball DE, McLaughlin WS, Seymour RA, Kamali F. Plasma and saliva concentrations of phenytoin and 5-(4- hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients. J Periodontol 1996;67: 597-602. (Pubitemid 26201578)
19. Vernillo AT, Schwartz NB. The effects of phenytoin (5,5- diphenylhydantoin) on human gingival fibroblasts in culture. J Periodontal Res 1987;22:307-312. (Pubitemid 18082971)